AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

P3 Health Partners Inc.

$8.43 +$4.93 (+140.86%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$8.36
Day Range
$8.35$8.5
Year Range
$1.52$16.89
Market Cap
27.62M
AVG Volume
1.29M
Trailing/Forward PE
-0.26/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD)
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2386.38M
26 Q1386.39M
25 Q4384.81M
25 Q3345.25M
25 Q2355.79M
25 Q1373.23M
24 Q4370.69M
24 Q3362.12M
24 Q2379.16M
24 Q1388.49M
Net Income (USD)
-100M-75M-50M-25M025M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q27.44M
26 Q11.22M
25 Q4-75.52M
25 Q3-31.59M
25 Q2-20.36M
25 Q1-20.48M
24 Q4-58.62M
24 Q3-46.51M
24 Q2-12.02M
24 Q1-18.7M
Operating Income (USD)
-200M-150M-100M-50M050M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q241.23M
26 Q18.24M
25 Q4-153.87M
25 Q3-44.22M
25 Q2-34.12M
25 Q1-38.09M
24 Q4-138.5M
24 Q3-106.99M
24 Q2-31.33M
24 Q1-43.83M
EBITDA (USD)
-150M-100M-50M050M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q245.82M
26 Q129.88M
25 Q4-130.12M
25 Q3-27.89M
25 Q2-10.46M
25 Q1-13.4M
24 Q4-96.21M
24 Q3-79.14M
24 Q2-677K
24 Q1-21.74M
Cash Flows (USD)
-80M-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-61.91M
26 Q1-27.47M
25 Q4-25.61M
25 Q3-15.41M
25 Q2-16.63M
25 Q1-33.47M
24 Q4-57.24M
24 Q3-22.62M
24 Q2-10.24M
24 Q1-20.03M
EPS (USD)
-30-20-1001024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.63
26 Q10.37
25 Q4-23.02
25 Q3-9.67
25 Q2-6.23
25 Q1-6.28
24 Q4-20.82
24 Q3-15.7
24 Q2-7.37
24 Q1-7.92
Expenses (USD)
010M20M30M40MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q232.39M
26 Q125.77M
25 Q436.21M
25 Q322.39M
25 Q223.45M
25 Q125.18M
24 Q431.83M
24 Q327.35M
24 Q227.02M
24 Q127.72M
Cash & Debt (USD)
0100M200M300MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q221.27M
26 Q125.5M
25 Q425.01M
25 Q337.71M
25 Q238.58M
25 Q140.08M
24 Q438.82M
24 Q362.96M
24 Q273.09M
24 Q127.3M
Debt ratios
-1.5-1-0.5024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Debt ratios by quarter
PeriodDebt ratios
26 Q2-1.32
26 Q1-0.27
25 Q4-1.43
25 Q3-0.09
25 Q2-0.77
25 Q1-0.75
24 Q4-0.64
24 Q3-0.57
24 Q2-0.97
24 Q1-1.38
Margins
-50%0%50%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Margins by quarter
PeriodMargins
26 Q222.26%
26 Q17.58%
25 Q4100%
25 Q3-7.11%
25 Q2100%
25 Q1-1.55%
24 Q4100%
24 Q3100%
24 Q23.69%
24 Q1-3.89%
Return on Capital
-200%-100%0%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Return on Capital by quarter
PeriodReturn on Capital
26 Q210.17%
26 Q1-0.92%
25 Q453.85%
25 Q3-166.88%
25 Q2-23.36%
25 Q1-16.91%
24 Q4-39.2%
24 Q3-17.62%
24 Q2-3.29%
24 Q1-4.85%
Shares Outstanding
01M2M3M4M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Shares Outstanding by quarter
PeriodShares Outstanding
26 Q23.36M
26 Q13.29M
25 Q43.28M
25 Q33.27M
25 Q23.27M
25 Q13.26M
24 Q43.25M
24 Q33.24M
24 Q22.73M
24 Q12.32M
Book Value Per Share (USD)
-100010020024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q221.77
26 Q1-40.5
25 Q4-42.74
25 Q35.79
25 Q226.68
25 Q137.14
24 Q445.97
24 Q381.5
24 Q2133.54
24 Q1166.49
Total Assets (USD)
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PIII Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q2654.39M
26 Q1674.16M
25 Q4656.64M
25 Q3683.56M
25 Q2731.59M
25 Q1783.87M
24 Q4783.42M
24 Q3833.33M
24 Q2892.76M
24 Q1855.92M
Employee Count
02004006002021202220242025
PIII Employee Count by quarter
PeriodEmployee Count
2025320
2024360
2022600
2021500
Free Cash Flow Yield
-2000%-1500%-1000%-500%0%med -451.77%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PIII Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-460.1%
Sep 26-414.83%
Aug 26-420.68%
Aug 26-376.2%
Aug 26-362.83%
Aug 26-223.56%
Jul 26-263.36%
Jul 26-269.11%
Jul 26-239.26%
Jul 26-264.16%
Jul 26-227.69%
Jun 26-228.9%
Jun 26-240.82%
Jun 26-211.68%
Jun 26-223.56%
May 26-212.55%
May 26-196.12%
May 26-229.3%
May 26-782.3%
May 26-947.84%
Apr 26-1051.96%
Apr 26-1068.14%
Apr 26-1093.37%
Apr 26-1080.61%
Mar 26-944.62%
Mar 26-1295.2%
Mar 26-1188.64%
Mar 26-1684.35%
Feb 26-1771.74%
Feb 26-1755.18%
Feb 26-1755.18%
Feb 26-1747.02%
Jan 26-1956.3%
Jan 26-1478.78%
Jan 26-1173.78%
Jan 26-1155.72%
Jan 26-1073.17%
Dec 25-1052.13%
Dec 25-911.67%
Dec 25-723.72%
Dec 25-716.81%
Nov 25-695.57%
Nov 25-657.81%
Nov 25-549.14%
Nov 25-502.88%
Oct 25-454.61%
Oct 25-449.98%
Oct 25-459.86%
Oct 25-432.37%
Oct 25-459.86%
Sep 25-407.56%
Sep 25-482.74%
Sep 25-462.54%
Sep 25-453.57%
Aug 25-477.53%
Aug 25-553.24%
Aug 25-586.7%
Aug 25-565.72%
Aug 25-515.69%
Jul 25-521.36%
Jul 25-573.42%
Jul 25-608.4%
Jul 25-594.09%
Jun 25-595.02%
Jun 25-606.45%
Jun 25-567.41%
Jun 25-572.55%
May 25-512.9%
May 25-519.22%
May 25-474.38%
May 25-388.72%
May 25-384.75%
Apr 25-378.72%
Apr 25-366.42%
Apr 25-445.49%
Apr 25-396%
Mar 25-391.42%
Mar 25-246.19%
Mar 25-241.97%
Mar 25-228.89%
Feb 25-224.05%
Feb 25-203.58%
Feb 25-184.11%
Feb 25-216.04%
Jan 25-235.25%
Jan 25-213.86%
Jan 25-205.56%
Jan 25-196.95%
Jan 25-170.74%
Dec 24-211.72%
Dec 24-214.95%
Dec 24-206.56%
Dec 24-183.31%
Nov 24-169.38%
Nov 24-198.8%
Nov 24-184.91%
Nov 24-105.24%
Nov 24-107.24%
Oct 24-97.21%
Oct 24-86.93%
Price to Sales
00.010.020.030.040.05med 0.02Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PIII Price to Sales by quarter
PeriodPrice to Sales
Sep 260.02
Sep 260.02
Aug 260.02
Aug 260.02
Aug 260.02
Aug 260.03
Jul 260.02
Jul 260.02
Jul 260.02
Jul 260.02
Jul 260.03
Jun 260.03
Jun 260.02
Jun 260.03
Jun 260.03
May 260.03
May 260.03
May 260.03
May 260.01
May 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Mar 260.01
Mar 260.01
Mar 260.01
Mar 260.01
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Dec 250.01
Dec 250.01
Dec 250.01
Dec 250.01
Nov 250.01
Nov 250.01
Nov 250.02
Nov 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Aug 250.01
Aug 250.02
Jul 250.02
Jul 250.01
Jul 250.01
Jul 250.01
Jun 250.01
Jun 250.01
Jun 250.01
Jun 250.01
May 250.02
May 250.02
May 250.02
May 250.02
May 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Feb 250.02
Feb 250.02
Feb 250.03
Feb 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Jan 250.03
Dec 240.02
Dec 240.02
Dec 240.02
Dec 240.03
Nov 240.03
Nov 240.02
Nov 240.03
Nov 240.04
Nov 240.04
Oct 240.04
Oct 240.04
Price to Book
00.511.5med 0.19Aug 24Nov 24Feb 25Jun 25Sep 25Jan 26Sep 26
PIII Price to Book by quarter
PeriodPrice to Book
Sep 260.39
Sep 260.43
Aug 260.42
Aug 260.47
Aug 260.49
Mar 260.5
Mar 260.55
Mar 260.39
Feb 260.37
Feb 260.37
Feb 260.37
Feb 260.37
Jan 260.33
Jan 260.44
Jan 260.55
Jan 260.56
Jan 260.6
Dec 250.62
Dec 250.71
Dec 250.9
Dec 250.9
Nov 250.93
Nov 250.99
Nov 251.18
Nov 250.3
Oct 250.33
Oct 250.33
Oct 250.32
Oct 250.34
Oct 250.32
Sep 250.37
Sep 250.31
Sep 250.32
Sep 250.33
Aug 250.31
Aug 250.27
Aug 250.25
Aug 250.18
Aug 250.2
Jul 250.2
Jul 250.18
Jul 250.17
Jul 250.17
Jun 250.17
Jun 250.17
Jun 250.18
Jun 250.18
May 250.2
May 250.2
May 250.22
May 250.19
May 250.19
Apr 250.19
Apr 250.2
Apr 250.17
Apr 250.19
Mar 250.19
Mar 250.11
Mar 250.11
Mar 250.11
Feb 250.12
Feb 250.13
Feb 250.14
Feb 250.12
Jan 250.11
Jan 250.12
Jan 250.13
Jan 250.13
Jan 250.15
Dec 240.12
Dec 240.12
Dec 240.13
Dec 240.14
Nov 240.15
Nov 240.13
Nov 240.14
Nov 240.14
Nov 240.14
Oct 240.15
Oct 240.17
Oct 240.12
Oct 240.14
Sep 240.15
Sep 240.16
Sep 240.18
Sep 240.17
Aug 240.19
Aug 240.19
Aug 240.22
Aug 240.23
Aug 240.18
Jul 240.19
Jul 240.17
Jul 240.16
Jul 240.15
Jun 240.14
Jun 240.17
Jun 240.19
Jun 240.17
May 240.15
P3 Health Partners Inc.
PIII
Stockpicker

Video analysis: PIII

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PIII

Analyzing Molina Healthcare (NYSE:MOH) and P3 Health Partners (NASDAQ:PIII)

defenseworld.net · 9 Sep 2026

Analyzing Molina Healthcare (NYSE:MOH) and P3 Health Partners (NASDAQ:PIII)

P3 Health Partners (NASDAQ: PIII - Get Free Report) and Molina Healthcare (NYSE: MOH - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends. Volatility and Risk P3 Health Partners has

P3 Health Partners Q2 Earnings Call Highlights

marketbeat.com · 10 Aug 2026

P3 Health Partners Q2 Earnings Call Highlights

P3 Health Partners NASDAQ: PIII reported second-quarter adjusted EBITDA of $54 million and raised its full-year 2026 outlook, while noting that the quarterly result included $45 million of favorable payer settlements and prior-year development.

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

seekingalpha.com · 10 Aug 2026

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript

P3 Health Partners Announces Second Quarter 2026 Results

businesswire.com · 10 Aug 2026

P3 Health Partners Announces Second Quarter 2026 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2026. "Q2 demonstrates that the business is now executing according to our plan. We delivered $54 million of adjusted EBITDA, with the core business driving improved profitability quarter over quarter. Our results reflect the structural improvements.

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

businesswire.com · 21 Jul 2026

P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2026 on Monday, August 10, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Second Quarter 2026 Earnings C.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.